These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23118468)

  • 1. Unrealistic optimism and the ethics of phase I cancer research.
    Crites J; Kodish E
    J Med Ethics; 2013 Jun; 39(6):403-6. PubMed ID: 23118468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can phase I cancer research studies in children be justified on ethical grounds?
    Ekert H
    J Med Ethics; 2013 Jun; 39(6):407. PubMed ID: 23175460
    [No Abstract]   [Full Text] [Related]  

  • 3. Informed Consent, Therapeutic Misconception, and Unrealistic Optimism.
    Jansen LA
    Perspect Biol Med; 2020; 63(2):359-373. PubMed ID: 33416658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation.
    Halpern J; Paolo D; Huang A
    J Med Ethics; 2019 Jun; 45(6):384-387. PubMed ID: 31189726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispositional optimism and therapeutic expectations in early-phase oncology trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WM; Weinstein ND; Mori M; Daffé R; Sulmasy DP
    Cancer; 2016 Apr; 122(8):1238-46. PubMed ID: 26882017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moral justification of Phase 1 oncology trials.
    Dubov A
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):138-51. PubMed ID: 24813655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presuming patient autonomy in the face of therapeutic misconception.
    McConville P
    Bioethics; 2017 Nov; 31(9):711-715. PubMed ID: 28857220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WMP; Weinstein ND; Mori M; Degnin C; Sulmasy DP
    J Empir Res Hum Res Ethics; 2017 Oct; 12(4):280-288. PubMed ID: 28728498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.
    Kimmelman J; Palmour N
    J Med Ethics; 2005 Apr; 31(4):209-14. PubMed ID: 15800361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient.
    Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG
    Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fair transaction model of informed consent: an alternative to autonomous authorization.
    Miller FG; Wertheimer A
    Kennedy Inst Ethics J; 2011 Sep; 21(3):201-18. PubMed ID: 22073815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.
    Weinfurt KP; Sulmasy DP; Schulman KA; Meropol NJ
    Theor Med Bioeth; 2003; 24(4):329-44. PubMed ID: 14620488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of control and unrealistic optimism in early-phase cancer trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WMP; Weinstein ND; Mori M; Degnin C; Sulmasy DP
    J Med Ethics; 2018 Feb; 44(2):121-127. PubMed ID: 28774957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.
    Horng S; Grady C
    IRB; 2003; 25(1):11-6. PubMed ID: 12833900
    [No Abstract]   [Full Text] [Related]  

  • 16. Manipulation in the enrollment of research participants.
    Mandava A; Millum J
    Hastings Cent Rep; 2013; 43(2):38-47. PubMed ID: 23390007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 3 Oncology Clinical Trials in South Africa: Experimentation or Therapeutic Misconception?
    Malan T; Moodley K
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):47-56. PubMed ID: 27106890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking Respect Seriously: Clinical Research and the Demands of Informed Consent.
    Jansen LA
    J Med Philos; 2018 May; 43(3):342-360. PubMed ID: 29746686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences.
    de Vries MC; Houtlosser M; Wit JM; Engberts DP; Bresters D; Kaspers GJ; van Leeuwen E
    BMC Med Ethics; 2011 Sep; 12():18. PubMed ID: 21943406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hope for better treatment in participating clinical drug trials.
    Keränen T; Pasternack A; Halkoaho A
    Duodecim; 2017; 133(6):587-91. PubMed ID: 29243475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.